Aurora Cannabis (ACB) vs SIGA Technologies (SIGA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Aurora Cannabis (ACB) has outperformed SIGA Technologies (SIGA) over the past year, losing 27.7% versus a loss of 61.4%. Over five years, SIGA leads with a -54.1% price change compared with -93.7% for ACB. Aurora Cannabis is the larger company by market cap ($282.4 million vs $234.2 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACB | SIGA |
|---|---|---|
| Share price | $4.46 | $3.26 |
| Market cap | $282.36M | $234.23M |
| 1-day change | -2.83% | -0.91% |
| YTD return | +5.69% | -46.64% |
| 1-year return | -27.71% | -61.37% |
| 5-year return | -93.66% | -54.15% |
| Forward P/E | — | 3.02 |
| EPS (TTM) | $-0.61 | $-0.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.67 | $8.55 |
| 52-week low | $2.56 | $2.83 |
| Distance from 52-week high | -33.08% | -61.87% |
| Analyst consensus | buy | none |
| Average volume | 1.36M | 731.22K |
| Shares outstanding | 63.31M | 71.85M |
| Employees | 1,028 | 49 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ACB has outperformed SIGA by 33.7 percentage points over the past year.
About Aurora Cannabis
ACB stock →Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products.
Healthcare · Drug Manufacturers - Specialty & Generic · 1,028 employees
About SIGA Technologies
SIGA stock →SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus.
Healthcare · Drug Manufacturers - Specialty & Generic · 49 employees
ACB vs SIGA FAQ
Which is bigger, Aurora Cannabis or SIGA Technologies?
Aurora Cannabis (ACB) is larger, with a market capitalization of $282.36M compared with $234.23M for SIGA Technologies (SIGA).
Which stock has performed better over the past year, ACB or SIGA?
ACB returned -27.71% over the past 12 months, compared with -61.37% for SIGA (price return, excluding dividends). Past performance does not predict future results.
Are Aurora Cannabis and SIGA Technologies in the same industry?
Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.